This article is a correction to:
New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count
Rocío del Campo-Pedrosa
Alfonso Martín-Carnicero
Ana González-Marcos
Alfredo Martínez- 1Data Department, Encore Lab S.L., Logroño, Spain
- 2Department of Mechanical Engineering, Universidad de La Rioja, Logroño, Spain
- 3Medical Oncology Department, Hospital San Pedro, Logroño, Spain
- 4Angiogenesis Group, Center for Biomedical Research of La Rioja (CIBIR), Logroño, Spain
A Corrigendum on
New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count
By del Campo-Pedrosa R, Martín-Carnicero A, González-Marcos A and Martínez A (2024) Front. Oncol. 14:1411096. doi: 10.3389/fonc.2024.1411096
In the published article, there was an error in Table 4 as published. Error was in the manual transcription of the numerical data of the Kaplan-Meier result. Specifically, the transcription error has occurred for the rows of ALP, GGT and LDH. The corrected Table 4 and its caption “Kaplan-Meier and log-rank values for statistically significant hematologic parameters grouped by the optimal cut-off” appear below.
Table 4
Table 4. Kaplan-Meier and log-rank values for statistically significant hematologic parameters grouped by the optimal cut-off.
In the published article, there was an error. The error corresponds to the paragraph in which numerical references are made to the Table 4 with the numerical transcription error.
A correction has been made to Results, Prognosis, Paragraph 3. This sentence previously stated:
“Those individuals whose values on GGT and LDH were below the cut-off point (Table 4) presented a better prognosis than the ones who were above; specifically, they presented an OS increase by 44.8%, and 74.6%, respectively (Figures 1B, C). For their part, ALP<102.00 (Figure 1A), number of leukocytes<8,000, neutrophiles<6,000 and monocytes<800 (Figures 1D–F) were also statistically significant, resulting in patients with low levels increasing their survival by 49.7%, 44.9%, 42.5% and 44.4%, respectively (Table 4).”
The corrected sentence appears below:
“Those individuals whose values on GGT and LDH were below the cut-off point (Table 4) presented a better prognosis than the ones who were above; specifically, they presented an OS increase by 39.3%, and 49.6%, respectively (Figures 1B, C). For their part, ALP<102.00 (Figure 1A), number of leukocytes<8,000, neutrophiles<6,000 and monocytes<800 (Figure 1D-F) were also statistically significant, resulting in patients with low levels increasing their survival by 41.8%, 44.9%, 42.4% and 44.3%, respectively (Table 4).”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: prognosis model, prognostic biomarkers, overall survival, gamma glutamyl transferase (GGT), lactate dehydrogenase (LDH), advanced and metastatic pancreatic cancer, pancreatic ductal adenocarcinoma (PDAC)
Citation: del Campo-Pedrosa R, Martín-Carnicero A, González-Marcos A and Martínez A (2025) Corrigendum: New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count. Front. Oncol. 14:1540165. doi: 10.3389/fonc.2024.1540165
Received: 05 December 2024; Accepted: 16 December 2024;
Published: 15 January 2025.
Edited and Reviewed by:
Sharon R. Pine, University of Colorado Anschutz Medical Campus, United StatesCopyright © 2025 del Campo-Pedrosa, Martín-Carnicero, González-Marcos and Martínez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Rocío del Campo-Pedrosa, cm9jaW9AZW5jb3JlLWxhYi5jb20=